Department of Molecular Immunology; Institute of Industrial Science; The University of Tokyo; Tokyo, Japan ; Core Research for Evolution Science and Technology; Japan Science and Technology Agency; Chiyoda-ku, Tokyo, Japan.
Oncoimmunology. 2012 Nov 1;1(8):1376-1386. doi: 10.4161/onci.22475.
Members of the interferon-regulatory factor (IRF) proteins family were originally identified as transcriptional regulators of the Type I interferon system. Thanks to consistent advances made in our understanding of the immunobiology of innate receptors, it is now clear that several IRFs are critical for the elicitation of innate pattern recognition receptors, and-as a consequence-for adaptive immunity. In addition, IRFs have attracted great attentions as they modulate cellular responses that are involved in tumorigenesis. The regulation of oncogenesis by IRFs has important implications for understanding the host susceptibility to several Types of cancers, their progression, as well as the potential for therapeutic interventions.
干扰素调节因子 (IRF) 蛋白家族成员最初被鉴定为 I 型干扰素系统的转录调节剂。由于我们对先天受体免疫生物学的理解不断取得进展,现在很清楚,几种 IRF 对于先天模式识别受体的诱导至关重要,并且——因此——对于适应性免疫。此外,IRF 还吸引了人们的极大关注,因为它们调节了参与肿瘤发生的细胞反应。IRF 对肿瘤发生的调节对理解宿主对几种类型癌症的易感性、癌症的进展以及治疗干预的可能性具有重要意义。